dacarbazine has been researched along with benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Apel, MA; Battastini, AM; Braganhol, E; Canedo, AD; da Frota, ML; Henriques, AT; Klamt, F; Lerner, C; Moreira, JC; Mothes, B | 1 |
| Fietkau, R; Frey, B; Gaipl, US; Werthmöller, N; Wunderlich, R | 1 |
2 other study(ies) available for dacarbazine and benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone
| Article | Year |
|---|---|
Brazilian marine sponge Polymastia janeirensis induces apoptotic cell death in human U138MG glioma cell line, but not in a normal cell culture.
Topics: Amino Acid Chloromethyl Ketones; Animals; Antineoplastic Agents; Apoptosis; Astrocytes; Brazil; Cell Line, Transformed; Cell Line, Tumor; Complex Mixtures; Dacarbazine; Glioma; Humans; Porifera; Temozolomide | 2009 |
Modulation of radiochemoimmunotherapy-induced B16 melanoma cell death by the pan-caspase inhibitor zVAD-fmk induces anti-tumor immunity in a HMGB1-, nucleotide- and T-cell-dependent manner.
Topics: Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Apyrase; B7-2 Antigen; Caspase Inhibitors; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Chemoradiotherapy; Combined Modality Therapy; Dacarbazine; Dendritic Cells; Histocompatibility Antigens Class II; HMGB1 Protein; Homeodomain Proteins; Hyperthermia, Induced; Interferon-gamma; Lymphocyte Activation; Macrophages, Peritoneal; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Knockout; Myeloid Differentiation Factor 88; Radiation, Ionizing; Tumor Necrosis Factor-alpha | 2015 |